Displaying drugs 8601 - 8625 of 9232 in total
Proglumetacin
Experimental
CoA-S-trimethylene-acetyl-tryptamine
Experimental
Trifluoroacetonyl coenzyme A
Experimental
Myristoyl-Coa
Experimental
Dodecyl-Coa
Experimental
Penimepicycline
Penimepicycline is a tetracycline-class antibiotic. It is mentioned on List A produced by the Government of Canada, which is a list of antimicrobial active pharmaceutical ingredients . In the classification of the active ingredients included on this list, the classification document states that tetracycline class antibiotics are of medium importance,...
Experimental
Domoic Acid
Experimental
3-Tyrosine
Experimental
4-Iodo-L-phenylalanine
Experimental
Trifluoromethionine
Experimental
Cp-Coeleneterazine
Experimental
CRA_9678
Experimental
Elacridar
Elacridar (GW120918) is an oral bioenhancer that targets multiple drug resistance in tumors. In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein inhibitors. As of August 2007 elacridar was not listed on GSK's product pipeline. Development is assumed to have...
Investigational
Matched Description: … In many cases, the appearance of multidrug resistance in cancer is due to a change in expression of protein …
Matched Salts cas: … 143851-98-3 …
Matched Salts cas: … 143851-98-3 …
Ispinesib
Investigational
Muraglitazar
Muraglitazar (Bristol-Myers Squibb/Merck) is a new agent under investigation for the treatment of patients with type 2 diabetes. It belongs to a novel class of drugs that target the peroxisome proliferator-activated receptors, both alpha and gamma subtypes. In addition to improvements in blood glucose and hemoglobin A1c (HbA1c), muraglitazar treatment...
Investigational
Displaying drugs 8601 - 8625 of 9232 in total